PubRank

H H Kanhai

Author PubWeight™ 51.98‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 [Rupture of the pregnant uterus]. Ned Tijdschr Geneeskd 1993 1.93
2 Outcome for children treated with fetal intravascular transfusions because of severe blood group antagonism. J Pediatr 1997 1.47
3 Iron overload, free radical damage, and rhesus haemolytic disease. Lancet 1990 1.44
4 The disappearance of fetal and donor red blood cells in alloimmunised pregnancies: a reappraisal. Br J Obstet Gynaecol 1997 1.44
5 Typing of fetal platelet alloantigens when platelets are not available. Lancet 1990 1.41
6 Detection of fetomaternal haemorrhage associated with cordocentesis using serum alpha-fetoprotein and the Kleihauer technique. Prenat Diagn 1995 1.41
7 Alterations in cord blood leukocyte subsets of patients with severe hemolytic disease after intrauterine transfusion therapy. J Pediatr 1997 1.39
8 [Blood group immunization: results of treatment of fetal anemia with intra-uterine intravascular blood transfusion in the Netherlands, 1987-1995]. Ned Tijdschr Geneeskd 1999 1.39
9 Reproductive age mortality survey to study under-reporting of maternal mortality in Surinam. Eur J Obstet Gynecol Reprod Biol 1998 1.10
10 Selective termination in quintuplet pregnancy during first trimester. Lancet 1986 0.99
11 The severity of immune fetal hydrops is predictive of fetal outcome after intrauterine treatment. Am J Obstet Gynecol 2001 0.97
12 Preeclampsia and genetic risk factors for thrombosis: a case-control study. Am J Obstet Gynecol 1999 0.96
13 beta-Glucuronidase deficiency as a cause of fetal hydrops. Am J Med Genet 1992 0.91
14 Safety of early amniocentesis. Lancet 1994 0.90
15 Cytogenetic findings in 1250 chorionic villus samples obtained in the first trimester with clinical follow-up of the first 1000 pregnancies. Br J Obstet Gynaecol 1989 0.90
16 No beneficial effect of low-dose fetal intravenous gammaglobulin administration in combination with intravascular transfusions in severe Rh D haemolytic disease. Vox Sang 1994 0.88
17 A less invasive treatment strategy to prevent intracranial hemorrhage in fetal and neonatal alloimmune thrombocytopenia. Am J Obstet Gynecol 2001 0.88
18 Induction of additional red cell alloantibodies after intrauterine transfusions. Transfusion 1994 0.88
19 Evidence of endothelium involvement in the pathophysiology of hydrops fetalis? Early Hum Dev 2000 0.86
20 Benefits and risks of fetal red-cell transfusion after 32 weeks gestation. Eur J Obstet Gynecol Reprod Biol 2000 0.85
21 Amniocentesis before 14 completed weeks as an alternative to transabdominal chorionic villus sampling: a controlled trial with infant follow-up. Prenat Diagn 1998 0.84
22 Twin anemia-polycythemia sequence in two monochorionic twin pairs without oligo-polyhydramnios sequence. Placenta 2006 0.83
23 Association of stress during delivery with increased numbers of nucleated cells and hematopoietic progenitor cells in umbilical cord blood. Am J Obstet Gynecol 2000 0.82
24 Fetal ductus venosus blood flow velocities before and after transfusion in red-cell alloimmunized pregnancies. Obstet Gynecol 1993 0.82
25 Blood gas and pH in the human fetus with severe anemia. Fetal Diagn Ther 1998 0.81
26 Fetal cell detection in maternal blood: a study in 236 samples using erythroblast morphology, DAB and HbF staining, and FISH analysis. Cytometry 1998 0.81
27 Multiple birth prevalence in The Netherlands. Impact of maternal age and assisted reproductive techniques. J Reprod Med 1998 0.81
28 First trimester prenatal diagnosis of haemophilia A: two years' experience. Prenat Diagn 1988 0.81
29 Influence of delivery on numbers of leukocytes, leukocyte subpopulations, and hematopoietic progenitor cells in human umbilical cord blood. Blood Cells 1994 0.81
30 Umbilical cord blood contains normal frequencies of cytotoxic T-lymphocyte precursors (ctlp) and helper T-lymphocyte precursors against noninherited maternal antigens and noninherited paternal antigens. Ann Hematol 1996 0.80
31 Effect of atracurium or pancuronium on the anemic fetus during and directly after intravascular intrauterine transfusion. A double blind randomized study. Acta Obstet Gynecol Scand 1999 0.80
32 Preventing the recurrence of atonic postpartum hemorrhage: a double-blind trial. Acta Obstet Gynecol Scand 1995 0.80
33 Congenital microcephaly, infantile spasms, psychomotor retardation, and nephrotic syndrome in two sibs. Eur J Pediatr 1987 0.79
34 Clinical value of an antibody-dependent cell-mediated cytotoxicity assay in the management of Rh D alloimmunization. Am J Obstet Gynecol 2001 0.78
35 The value of routine cervical cultures before transcervical chorionic villus sampling. Prenat Diagn 1989 0.78
36 Genotype assignment of haemophilia A by use of intragenic and extragenic restriction fragment length polymorphisms. Thromb Haemost 1987 0.78
37 Survival of donor cells 25 years after intrauterine transfusion. Blood 2000 0.78
38 Strategies for rare-event detection: an approach for automated fetal cell detection in maternal blood. Am J Hum Genet 1998 0.78
39 Low dose sulprostone for termination of second and third trimester pregnancies. Eur J Obstet Gynecol Reprod Biol 2001 0.78
40 An evaluation of 75 terminations of pregnancy based on abnormal laboratory findings at first trimester CVS. Clin Genet 1990 0.78
41 Fetal and maternal energy metabolism during labor in relation to the available caloric substrate. J Perinat Med 2001 0.78
42 Human platelet antigen-1 (Zw) typing of fetuses by analysis of polymerase chain reaction-amplified genomic DNA from amniocytes. Transfus Med 1994 0.78
43 Safety of chorionic villus sampling. Lancet 1985 0.78
44 Prenatal diagnosis of lysosomal storage diseases using fetal blood. Prenat Diagn 1999 0.78
45 Fetal thrombocytopenia. Curr Opin Obstet Gynecol 1998 0.78
46 The contribution of DNA analysis to carrier detection and prenatal diagnosis of hemophilia A and B. Ann Hematol 1992 0.77
47 Chorionic villi sampling: cytogenetic and clinical findings in 500 pregnancies. Br Med J (Clin Res Ed) 1987 0.77
48 Detection of 'rare event' fetal erythroblasts in maternal blood using automated microscopy. Early Hum Dev 1996 0.77
49 Ketanserin versus dihydralazine in the management of severe early-onset preeclampsia: maternal outcome. Am J Obstet Gynecol 1999 0.77
50 [Rhesus antagonism]. Ned Tijdschr Geneeskd 1986 0.77
51 Development of a preparation and staining method for fetal erythroblasts in maternal blood: simultaneous immunocytochemical staining and FISH analysis. Cytometry 1998 0.77
52 Two-colour immunocytochemical staining of gamma (gamma) and epsilon (epsilon) type haemoglobin in fetal red cells. Prenat Diagn 1998 0.76
53 [Less medicalization of obstetrics in West Friesian islands than on the mainland]. Ned Tijdschr Geneeskd 2000 0.75
54 Prenatal diagnosis of trisomy 13 on fetal cells obtained from maternal blood after minor enrichment. Prenat Diagn 1998 0.75
55 [Prenatal treatment of allo-immune thrombocytopenia using high-dose IgG]. Ned Tijdschr Geneeskd 1993 0.75
56 [10 years of chorionic villi sampling and the weighing against amniocentesis]. Ned Tijdschr Geneeskd 1993 0.75
57 Assessment of prenatal karyotypes. Hum Reprod 2000 0.75
58 ABO and Rhesus phenotyping of fetal erythrocytes in the first trimester of pregnancy. Br J Haematol 1986 0.75
59 [Vasa praevia]. Ned Tijdschr Geneeskd 1982 0.75
60 Evidence for the protective effect of maternal FcR-blocking IgG alloantibodies HLA-DR in Rh D-haemolytic disease of the newborn. Vox Sang 1993 0.75
61 [The neglected blood pressure determination in pregnancy]. Ned Tijdschr Geneeskd 1989 0.75
62 Prenatal diagnosis of homozygous alpha zero-thalassemia by an immunological method. Ann N Y Acad Sci 1994 0.75
63 [What can be done for mother and infant in the case of irregular antibodies in pregnant Jehovah's witnesses?]. Ned Tijdschr Geneeskd 1987 0.75
64 [Evaluation of gradual conversion to a less invasive therapeutic strategy for pregnant women with alloimmune thrombocytopenia in the fetus for prevention of intracranial hemorrhage]. Ned Tijdschr Geneeskd 2000 0.75
65 Intrauterine transfusions influence fetal leukocyte counts and subsets. Prenat Diagn 1998 0.75
66 [The neglected blood pressure determination in pregnancy]. Ned Tijdschr Geneeskd 1989 0.75
67 Engraftment potential into NOD/SCID mice of CD34+ cells derived from human fetal liver as compared to fetal bone marrow. Haematologica 2001 0.75
68 Apparent relationship between vacuolization of fetal erythrocytes and anemia in red cell alloimmunization. Vox Sang 1995 0.75
69 'Hydatoxi lualba', an artefact. Eur J Obstet Gynecol Reprod Biol 1984 0.75
70 Twenty-two years of intra-uterine intraperitoneal transfusions. Eur J Obstet Gynecol Reprod Biol 1989 0.75
71 Eating and drinking in labor: the influence of caregiver advice on women's behavior. Birth 2001 0.75
72 Fetal hematopoiesis during first and second trimester of pregnancy: relevance for in utero stem cell transplantation. Ernst Schering Res Found Workshop 2001 0.75
73 Refractory rhesus (D) disease. Br J Obstet Gynaecol 1994 0.75
74 Separation, enrichment, and characterization of human hematopoietic progenitor cells from umbilical cord blood. Ann Hematol 1993 0.75
75 [Vaginal discharge as the principal symptom in an unusual urogenital anomaly]. Ned Tijdschr Geneeskd 1981 0.75
76 Fetal blood group determination in first-trimester pregnancy for the management of severe immunization. Am J Obstet Gynecol 1987 0.75
77 The use of ultrasonography and Doppler in the prediction of fetal haemolytic anaemia: a multivariate analysis. Br J Obstet Gynaecol 1994 0.75
78 Ultrasonographic fetal spleen measurements in red blood cell-alloimmunized pregnancies. Am J Obstet Gynecol 1993 0.75
79 Maternal hydrops syndrome: a review. Obstet Gynecol Surv 1991 0.75
80 [Care in stillbirth; mothers' opinion]. Ned Tijdschr Geneeskd 1990 0.75
81 Intrauterine transfusions affect fetal T-cell immunity. Blood 1997 0.75
82 [Prenatal fetal blood group determination using chorionic villi biopsy]. Ned Tijdschr Geneeskd 1989 0.75
83 Chorionic biopsy in management of severe rhesus isoimmunisation. Lancet 1984 0.75
84 Misleading results in the determination of haemolytic disease of the newborn using antibody titration and ADCC in a woman with anti-Lub. Vox Sang 1992 0.75
85 Nationwide maternal mortality in Surinam. Br J Obstet Gynaecol 1999 0.75
86 Skewing of TCR V genes to CD4+ and CD8+ subsets of T lymphocytes is not determined by amino acid composition of CDR3. Int Immunol 1997 0.75
87 A near false-negative finding of mosaic trisomy 21--a cautionary tale. Prenat Diagn 1998 0.75
88 The outcome of pregnancies with confined placental chromosome mosaicism in cytotrophoblast cells. Prenat Diagn 1996 0.75
89 Detection of fetal erythroblasts in maternal blood by one-step gradient enrichment and immunocytochemical recognition. Early Hum Dev 1996 0.75
90 [The initial results of fetoscopic laser treatment for severe second trimester twin-to-twin transfusion syndrome in the Netherlands are comparable to international results]. Ned Tijdschr Geneeskd 2004 0.75